101 related articles for article (PubMed ID: 17889151)
1. Study of anemia after late introduction of everolimus in the immunosuppressive treatment of renal transplant patients.
Sánchez Fructuoso A; Calvo N; Moreno MA; Giorgi M; Barrientos A
Transplant Proc; 2007 Sep; 39(7):2242-4. PubMed ID: 17889151
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus interferes with iron homeostasis in renal transplant recipients.
Maiorano A; Stallone G; Schena A; Infante B; Pontrelli P; Schena FP; Grandaliano G
Transplantation; 2006 Oct; 82(7):908-12. PubMed ID: 17038905
[TBL] [Abstract][Full Text] [Related]
3. Anemia in kidney transplants without erythropoietic agents: levels of erythropoietin and iron parameters.
Florit EA; Hadad F; Rodriguez Cubillo B; De la Flor JC; Valga F; Perez Flores I; Calvo Romero N; Valero San Cecilio R; Barrientos Guzman A; Sanchez Fructuoso A
Transplant Proc; 2012 Nov; 44(9):2590-2. PubMed ID: 23146464
[TBL] [Abstract][Full Text] [Related]
4. Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report.
Moreno A; Bárcena R; García-Gonzalez M; García-Hoz F; Quereda C; Casado JL; Pérez-Elías MJ; Fortún J; Nuño J; Arranz I; Moreno S
Transplant Proc; 2008 Dec; 40(10):3810-2. PubMed ID: 19100499
[TBL] [Abstract][Full Text] [Related]
5. Effects of everolimus monotherapy on hematological parameters and iron homeostasis in de novo liver transplant recipients: preliminary results.
Masetti M; Rompianesi G; Montalti R; Romano A; Spaggiari M; Ballarin R; Guerrini GP; Gerunda GE
Transplant Proc; 2008; 40(6):1947-9. PubMed ID: 18675097
[TBL] [Abstract][Full Text] [Related]
6. Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium.
Augustine JJ; Rodriguez V; Padiyar A; Bodziak KA; Schulak JA; Hricik DE
Transplantation; 2008 Aug; 86(4):548-53. PubMed ID: 18724224
[TBL] [Abstract][Full Text] [Related]
7. Iron deficiency in the acute-phase reaction after open aortic surgery.
Solis JV; Portero JL; Diaz J; Garcia R; Ligero JM; Vazquez E; Lodeiro C; Ballesteros L
Vasc Endovascular Surg; 2006; 40(5):392-8. PubMed ID: 17038573
[TBL] [Abstract][Full Text] [Related]
8. Anaemia, microcytosis and sirolimus--is iron the missing link?
Sofroniadou S; Kassimatis T; Goldsmith D
Nephrol Dial Transplant; 2010 May; 25(5):1667-75. PubMed ID: 20054028
[TBL] [Abstract][Full Text] [Related]
9. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients.
Malyszko J; Malyszko JS; Mysliwiec M
Transplant Proc; 2009 Oct; 41(8):3056-9. PubMed ID: 19857675
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anemia in renal transplant patients: results from MOST, an observational trial.
Fernández Fresnedo G; Palomar R; Rodrigo E; Ruiz JC; de Francisco AL; Cotorruelo JG; Arias M
Transplant Proc; 2005 Nov; 37(9):3821-2. PubMed ID: 16386550
[TBL] [Abstract][Full Text] [Related]
11. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
[TBL] [Abstract][Full Text] [Related]
12. Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function.
Friend P; Russ G; Oberbauer R; Murgia MG; Tufveson G; Chapman J; Blancho G; Mota A; Grandaliano G; Campistol JM; Brault Y; Burke JT;
Transpl Int; 2007 Sep; 20(9):754-60. PubMed ID: 17565578
[TBL] [Abstract][Full Text] [Related]
13. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
14. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience.
Santos SM; Carlos CM; Cabanayan-Casasola CB; Danguilan RA
Transplant Proc; 2012 Jan; 44(1):154-60. PubMed ID: 22310603
[TBL] [Abstract][Full Text] [Related]
15. Serum transferrin receptor in children: usefulness for determinating the nature of anemia in infection.
Angeles Vázquez López M; Molinos FL; Carmona ML; Morales AC; Muñoz Vico FJ; Muñoz JL; Muñoz Hoyos A
J Pediatr Hematol Oncol; 2006 Dec; 28(12):809-15. PubMed ID: 17164650
[TBL] [Abstract][Full Text] [Related]
16. Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes.
Niccoli L; Nannini C; Cassarà E; Kaloudi O; Cantini F
Int J Rheum Dis; 2012 Feb; 15(1):56-61. PubMed ID: 22324947
[TBL] [Abstract][Full Text] [Related]
17. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
18. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
19. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
20. Influence of inflammation on the relation between markers of iron deficiency in renal replacement therapy.
Yavuz A; Akbaş SH; Tuncer M; Kolağasi O; Cetinkaya R; Gürkan A; Demirbaş A; Gultekin M; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):41-3. PubMed ID: 15013295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
